{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:40:37Z","timestamp":1784774437962,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008231","name":"Arkansas Biosciences Institute","doi-asserted-by":"publisher","award":["ABI-TKSK-2016-17"],"award-info":[{"award-number":["ABI-TKSK-2016-17"]}],"id":[{"id":"10.13039\/100008231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1 RO1 CA 172631"],"award-info":[{"award-number":["1 RO1 CA 172631"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 GM103450"],"award-info":[{"award-number":["P30 GM103450"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-FG02-01ER15161"],"award-info":[{"award-number":["DE-FG02-01ER15161"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bbrc.2019.08.029","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T08:08:00Z","timestamp":1565683680000},"page":"191-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity"],"prefix":"10.1016","volume":"518","author":[{"given":"Rebecca","family":"Kerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanhita","family":"Maity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanuprasanth","family":"Koppolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Jayanthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Suresh Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Kumar","family":"Gundampati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"McNabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Zaharoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thallapuranam Krishnaswamy Suresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.08.029_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.abb.2018.07.017","article-title":"Probing the role of proline\u00a0\u2212135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor","volume":"654","author":"Davis","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2019.08.029_bib2","first-page":"45","article-title":"Effect of extension of the heparin binding pocket on the structure, stability, and cell proliferation activity of the human acidic fibroblast growth factor","volume":"13","author":"Davis","year":"2018","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrc.2019.08.029_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jb\/mvq121","article-title":"Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease","volume":"149","author":"Itoh","year":"2011","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.bbrc.2019.08.029_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrm3528","article-title":"Exploring mechanisms of FGF signalling through the lens of structural biology","volume":"14","author":"Goetz","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2019.08.029_bib5","doi-asserted-by":"crossref","first-page":"25388","DOI":"10.1074\/jbc.M109.001289","article-title":"Increased protein stability of FGF1 can compensate for its reduced affinity for heparin","volume":"284","author":"Zakrzewska","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.08.029_bib6","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1111\/j.1742-4658.2006.05474.x","article-title":"Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue","volume":"273","author":"Canales","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2019.08.029_bib7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1067\/mva.2003.177","article-title":"R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue","volume":"37","author":"Erzurum","year":"2003","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.bbrc.2019.08.029_bib8","doi-asserted-by":"crossref","first-page":"29682","DOI":"10.1074\/jbc.M504389200","article-title":"Time-dependent changes in the denatured state(s) influence the folding mechanism of an all \u03b2-Sheet protein","volume":"280","author":"Kathir","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.08.029_bib9","doi-asserted-by":"crossref","first-page":"15350","DOI":"10.1021\/bi026218a","article-title":"Investigation of the structural stability of the human acidic fibroblast growth factor by Hydrogen\u2212Deuterium exchange","volume":"41","author":"Chi","year":"2002","journal-title":"Biochemist"},{"key":"10.1016\/j.bbrc.2019.08.029_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbrc.2012.07.104","article-title":"Molecular basis for the Kallmann syndrome-linked fibroblast growth factor receptor mutation","volume":"425","author":"Thurman","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2019.08.029_bib11","doi-asserted-by":"crossref","first-page":"46424","DOI":"10.1074\/jbc.M207814200","article-title":"Structure and stability of an acidic fibroblast growth factor from Notophthalmus viridescens*210","volume":"277","author":"Arunkumar","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.08.029_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.carpath.2006.11.004","article-title":"Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in\u00a0vitro and in\u00a0vivo","volume":"16","author":"Li","year":"2007","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.bbrc.2019.08.029_bib13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0008-6363(02)00494-7","article-title":"Angiogenesis-independent cardioprotection in fgf-1 transgenic mice","volume":"55","author":"Buehler","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2019.08.029_bib14","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/cvr\/cvx165","article-title":"A\u00a0novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration","volume":"113","author":"Huang","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2019.08.029_bib15","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.celrep.2017.06.063","article-title":"Uncoupling the mitogenic and metabolic functions of FGF1 by tuning FGF1-FGF receptor dimer stability","volume":"20","author":"Huang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2019.08.029_bib16","doi-asserted-by":"crossref","first-page":"25388","DOI":"10.1074\/jbc.M109.001289","article-title":"Increased protein stability of FGF1 can compensate for its reduced affinity for heparin","volume":"284","author":"Zakrzewska","year":"2009","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19315402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19315402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:24:25Z","timestamp":1777393465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19315402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0006291X19315402"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.029","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of a thrombin resistant human acidic fibroblast growth factor (hFGF1) variant that exhibits enhanced cell proliferation activity","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}